Cai Fengfeng, Chen Ping, Chen Li, Biskup Ewelina, Liu Yan, Chen Pei-Chao, Chang Jian-Feng, Jiang Wenjie, Jing Yuanya, Chen Youwei, Jin Hui, Chen Su
School of Life Sciences and Technology, Department of Breast Surgery of Yangpu Hospital, Research Center for Translational Medicine at East Hospital, Tongji University, Shanghai, P. R. China.
Department of Oncology, University Hospital of Basel, Basel, Switzerland.
PLoS One. 2014 Nov 19;9(11):e113727. doi: 10.1371/journal.pone.0113727. eCollection 2014.
Protein ubiquitinylation regulates protein stability and activity. RAD6, an E2 ubiquitin-conjugating enzyme, which that has been substantially biochemically characterized, functions in a number of biologically relevant pathways, including cell cycle progression. In this study, we show that RAD6 promotes the G1-S transition and cell proliferation by regulating the expression of cyclin D1 (CCND1) in human cells. Furthermore, our data indicate that RAD6 influences the transcription of CCND1 by increasing monoubiquitinylation of histone H2B and trimethylation of H3K4 in the CCND1 promoter region. Our study presents, for the first time, an evidence for the function of RAD6 in cell cycle progression and cell proliferation in human cells, raising the possibility that RAD6 could be a new target for molecular diagnosis and prognosis in cancer therapeutics.
蛋白质泛素化调节蛋白质的稳定性和活性。RAD6是一种E2泛素结合酶,已得到充分的生化特性表征,在许多生物学相关途径中发挥作用,包括细胞周期进程。在本研究中,我们表明RAD6通过调节人细胞中细胞周期蛋白D1(CCND1)的表达来促进G1-S期转换和细胞增殖。此外,我们的数据表明,RAD6通过增加组蛋白H2B的单泛素化和CCND1启动子区域H3K4的三甲基化来影响CCND1的转录。我们的研究首次提供了RAD6在人细胞的细胞周期进程和细胞增殖中发挥功能的证据,这增加了RAD6可能成为癌症治疗中分子诊断和预后新靶点的可能性。